Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,269.05
-109.30 (-7.93%)
At close: Oct 28, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 132.71 billion as of October 28, 2026. Its market cap has decreased by 12.98% in one year.
Market Cap
132.71B
Enterprise Value
128.23B
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
47.24
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 132.71B, an increase of 34.55%. That is a compound annual growth rate of 9.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 132.71B | -5.73% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 543.69B |
| Anthem Biosciences | 472.91B |
| OneSource Specialty Pharma | 176.22B |
| Concord Biotech | 139.55B |
| Blue Jet Healthcare | 94.21B |
| Supriya Lifescience | 68.05B |
| Zota Health Care | 43.03B |
| Dishman Carbogen Amcis | 23.22B |